LY-307,452

LY-307,452
(IUPAC) ime
	(2S,4S)-2-amino-4-(4,4-difenilbut-1-il)pentan-1,5-dioiska kiselina
Klinički podaci
Identifikatori
ATC kod	nije dodeljen
PubChem	6324634
Hemijski podaci
Formula	C21H25NO4
Mol. masa	355,428 g/mol
SMILES	eMolekuli & PubHem
InChI
	InChI=1S/C21H25NO4/c22-19(21(25)26)14-17(20(23)24)12-7-13-18(15-8-3-1-4-9-15)16-10-5-2-6-11-16/h1-6,8-11,17-19H,7,12-14,22H2,(H,23,24)(H,25,26)/t17-,19-/m0/s1 ; Key: DWLOVDOPFJPWNE-HKUYNNGSSA-N
Farmakoinformacioni podaci
Trudnoća	?
Pravni status

LY-307,452 je lek koji se koristi u naučnim istraživanjima. On je bio među prvim jedinjenjima koja su delovala kao selektivni antagonisti za grupu II metabotropnih glutamatnih receptora (mGluR_2/3),^[3] i bio je koristan u ranim ispitivanjima te receptorske familije,^[4]^[5] mada je u međuvremenu uglavnom zamenjen novijim lekovima poput LY-341,495.

Reference

↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑ Wermuth CG, Mann A, Schoenfelder A, Wright RA, Johnson BG, Burnett JP, Mayne NG, Schoepp DD (February 1996). „(2S,4S)-2-amino-4-(4,4-diphenylbut-1-yl)-pentane-1,5-dioic acid: a potent and selective antagonist for metabotropic glutamate receptors negatively linked to adenylate cyclase”. Journal of Medicinal Chemistry 39 (4): 814–6. DOI:10.1021/jm9508144. PMID 8632404.
↑ Li XC, Beart PM, Monn JA, Jones NM, Widdop RE (October 1999). „Type I and II metabotropic glutamate receptor agonists and antagonists evoke cardiovascular effects after intrathecal administration in conscious rats”. British Journal of Pharmacology 128 (3): 823–9. DOI:10.1038/sj.bjp.0702850. PMC 1571690. PMID 10516668.
↑ Sung KW, Choi S, Lovinger DM (November 2001). „Activation of group I mGluRs is necessary for induction of long-term depression at striatal synapses”. Journal of Neurophysiology 86 (5): 2405–12. PMID 11698530.

Spoljašnje veze

	Portal Medicina
	Portal Hemija

[1] Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit

[2] Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.

[pmid8632404-3] Wermuth CG, Mann A, Schoenfelder A, Wright RA, Johnson BG, Burnett JP, Mayne NG, Schoepp DD (February 1996). „(2S,4S)-2-amino-4-(4,4-diphenylbut-1-yl)-pentane-1,5-dioic acid: a potent and selective antagonist for metabotropic glutamate receptors negatively linked to adenylate cyclase”. Journal of Medicinal Chemistry 39 (4): 814–6. DOI:10.1021/jm9508144. PMID 8632404.

[pmid10516668-4] Li XC, Beart PM, Monn JA, Jones NM, Widdop RE (October 1999). „Type I and II metabotropic glutamate receptor agonists and antagonists evoke cardiovascular effects after intrathecal administration in conscious rats”. British Journal of Pharmacology 128 (3): 823–9. DOI:10.1038/sj.bjp.0702850. PMC 1571690. PMID 10516668.

[pmid11698530-5] Sung KW, Choi S, Lovinger DM (November 2001). „Activation of group I mGluRs is necessary for induction of long-term depression at striatal synapses”. Journal of Neurophysiology 86 (5): 2405–12. PMID 11698530.

[1]

[2]

[3]

[4]

[5]